Publication | Closed Access

Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro

Tumor BiologyAction DeterminationsOncologyPancreatic CancerGastrointestinal OncologyMedicineTumor GrowthPharmacotherapyPharmacologyCell BiologyTumor MicroenvironmentCancer Research